Puzo Michael J Edwards Lifesciences Corp Transaction History

Puzo Michael J

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $163,215 - $215,010	-2,250 Reduced 40.18%	3,350 $320,000
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $590,379 - $743,929	-9,567 Reduced 63.08%	5,600 $427,000
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $44,685 - $60,230	645 Added 4.44%	15,167 $1.05 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $74,897 - $86,783	920 Added 6.76%	14,522 $1.37 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $393,726 - $448,072	5,302 Added 63.88%	13,602 $1.13 Million
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $796,378 - $1.02 Million	-11,660 Reduced 58.42%	8,300 $619,000
Q3 2022 Nov 08, 2022	BUY	$82.37 - $107.29 $456,741 - $594,923	5,545 Added 38.47%	19,960 $1.65 Million
Q2 2022 Jul 19, 2022	BUY	$86.5 - $128.27 $331,987 - $492,300	3,838 Added 36.29%	14,415 $1.37 Million
Q1 2022 May 17, 2022	BUY	$101.96 - $128.34 $408,553 - $514,258	4,007 Added 60.99%	10,577 $1.25 Million
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $698,850 - $858,567	6,570 New	6,570 $851,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Puzo Michael J, based on Form 13F filings with the SEC.

Stay updated on Puzo Michael J with notifications on news.